These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 22420895

  • 1. Oral mucosal hyperpigmentation and horizontal melanonychia caused by imatinib.
    Steele JC, Triantafyllou A, Rajlawat BP, Field EA.
    Clin Exp Dermatol; 2012 Jun; 37(4):432-3. PubMed ID: 22420895
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Imatinib: a designer drug, another cutaneous complication.
    Dickens E, Lewis F, Bienz N.
    Clin Exp Dermatol; 2009 Jul; 34(5):603-4. PubMed ID: 19486036
    [Abstract] [Full Text] [Related]

  • 4. Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia.
    Prabhash K, Biswas G, Prasad N, Karant N, Sastry PS, Parikh PM.
    Indian J Dermatol Venereol Leprol; 2006 Jul; 72(1):63-4. PubMed ID: 16481719
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Oral lichenoid eruption associated with imatinib treatment.
    Gómez Fernández C, Sendagorta Cudós E, Casado Verrier B, Feito Rodríguez M, Suárez Aguado J, Vidaurrázaga Díaz de Arcaya C.
    Eur J Dermatol; 2010 Jul; 20(1):127-8. PubMed ID: 19825526
    [No Abstract] [Full Text] [Related]

  • 8. Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia.
    Deguchi N, Kawamura T, Shimizu A, Kitamura R, Yanagi M, Shibagaki N, Matsue H, Shimada S.
    Br J Dermatol; 2006 Jun; 154(6):1216-8. PubMed ID: 16704666
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Adverse effects of imatinib mesylate].
    Isshiki I.
    Nihon Rinsho; 2007 Jan 28; 65 Suppl 1():404-7. PubMed ID: 17474438
    [No Abstract] [Full Text] [Related]

  • 12. Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases.
    Pascual JC, Matarredona J, Miralles J, Conesa V, Borras-Blasco J.
    Int J Dermatol; 2006 Dec 28; 45(12):1471-3. PubMed ID: 17184272
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Imatinib mesylate induces massive and nonspecific aminoaciduria in CML patients.
    Ianotto JC, Tempescul A, Amet Y, Grall P, Dalbies F, Eveillard JR, Guillerm G, Berthou C.
    Am J Hematol; 2012 Apr 28; 87(4):437-9. PubMed ID: 22287505
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.